Anti-trust regulators in Japan reportedly approved the $6.5 billion acquisition of Toshiba‘s (TYO:6502) medical device business to Canon (NYSE:CAJ), but warned about the deal’s questionable structure. Toshiba managed to book the sale before the deal actually closed by setting up a holding company with just $300 in assets to skirt Japanese anti-trust regulations. Yesterday Japan’s Fair Trade Commission said the method […]
Japan Fair Trade Commission
Japan OKs $13B Zimmer-Biomet merger
Second suitor cedes the field early to Zimmer | The week in medtech M&A
Japan probes Biomet-Zimmer merger
